Redx Pharma Plc announced that Sarah Gordon-Wild, independent non-executive director on the Board of Directors has resigned, for personal reasons, as a director of the company effective at the end of the company's current financial year on 30 September 2023. Ms. Gordon-Wild was appointed to the Board on 1 June 2020. At this time, the Company does not intend to appoint a replacement independent non-executive director to the Board following Ms. Gordon-Wild's resignation becoming effective.

Ms. Gordon-Wild is currently Chair of the Remuneration Committee and a member of the Audit Committee of the Board. Following her resignation becoming effective, it is intended that Dr. Bernhard Kirschbaum will be appointed Chair of the Remuneration Committee. The Board does not currently intend to appoint a replacement director for Ms. Gordon-Wild to either Committee.